인쇄하기
취소

Estechpharma to expand aceclofenac export

Published: 2008-09-25 06:44:00
Updated: 2008-09-25 06:44:00
EstechPharma is making its full efforts to expand its market share in the European market as its aceclofenac has been additionally approved by EDQM (European Directorate for the Quality of Medicines) through on-inspection last October, following the approval of acamprosate in June.

With the EDQM’s approval of aceclofenac, the company will be in a position to make a larger share in the Europe...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.